MY134868A - Improved growth stimulant compositions - Google Patents

Improved growth stimulant compositions

Info

Publication number
MY134868A
MY134868A MYPI99004773A MYPI9904773A MY134868A MY 134868 A MY134868 A MY 134868A MY PI99004773 A MYPI99004773 A MY PI99004773A MY PI9904773 A MYPI9904773 A MY PI9904773A MY 134868 A MY134868 A MY 134868A
Authority
MY
Malaysia
Prior art keywords
growth stimulant
improved growth
release
improved
stimulant compositions
Prior art date
Application number
MYPI99004773A
Other languages
English (en)
Inventor
Shih Chung
Thomas J Kennedy
Knight Peter James
Daniel S Robins
Shao Zezhi Jesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MY134868A publication Critical patent/MY134868A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI99004773A 1998-11-04 1999-11-03 Improved growth stimulant compositions MY134868A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
MY134868A true MY134868A (en) 2007-12-31

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99004773A MY134868A (en) 1998-11-04 1999-11-03 Improved growth stimulant compositions

Country Status (11)

Country Link
AR (1) AR025133A1 (es)
AU (1) AU777393B2 (es)
BR (2) BR9914996A (es)
CA (1) CA2348841C (es)
CO (1) CO5140100A1 (es)
CR (1) CR6351A (es)
MY (1) MY134868A (es)
PE (1) PE20001092A1 (es)
TW (1) TWI250027B (es)
WO (1) WO2000025743A2 (es)
ZA (1) ZA200103494B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4000688A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001288A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
CA2348841A1 (en) 2000-05-11
BRPI9914996B8 (pt) 2021-07-06
AR025133A1 (es) 2002-11-13
BR9914996A (pt) 2001-07-10
WO2000025743A3 (en) 2000-08-24
AU777393B2 (en) 2004-10-14
CA2348841C (en) 2007-04-17
WO2000025743A2 (en) 2000-05-11
BRPI9914996A (pt) 2001-07-10
PE20001092A1 (es) 2000-10-31
ZA200103494B (en) 2002-07-30
BRPI9914996B1 (pt) 2011-11-01
TWI250027B (en) 2006-03-01
CO5140100A1 (es) 2002-03-22
AU3096700A (en) 2000-05-22
CR6351A (es) 2003-11-20

Similar Documents

Publication Publication Date Title
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
DK0862416T3 (da) Ikke-polymert indgivelsessystem med forhalet frigørelse
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
MY125485A (en) Oral treatment of companion animals with extoparasiticidal spinosyns.
EE9900288A (et) Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
JP2010500975A (ja) ホルモン依存性癌の治療のためのｌｈｒｈアナログの初期量及びｌｈｒｈアンタゴニストの維持量の適用及びこの相応する製薬的キット
MY134868A (en) Improved growth stimulant compositions
BR9106676A (pt) Peptideo,processo para promover a liberacao de niveis de hormonio de crescimento em um animal,composicao farmaceutica para promover a liberacao de niveis de hormonio de crescimento em animais,uso do composto e processo para promover a liberacao e elevacao de niveis de hormonio de crescimento no sangue
Michael et al. Use of GnRH agonist implants for long-term suppression of fertility in extensively managed heifers and cows
US20010041697A1 (en) Implant composition containing melengestrol acetate and trenbolone acetate
NZ219300A (en) Veterinary composition for release of actives into the rumen
YU14700A (sh) UPOTREBA 8a-AZALIDA U VETERINI KAO ANTIMIKROBNA SREDSTVA
TH48412A3 (th) องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง
ECSP993205A (es) Composiciones estimulantes del crecimiento mejoradas (caso aho948)
RU96103819A (ru) Кормовая добавка для молодняка крупного рогатого скота
EP1177785A3 (en) Growth promoting pharmaceutical implant
UA85060C2 (ru) Биологически активная добавка к пище
WO2002038103A3 (en) Probiotic compositions and methods against bacterial infection in livestock animals
MXPA99005235A (es) Composicion antibacteriana oral veterinaria de fluoroquinolona para duracion extendida de terapia ymetodo de tratamiento.
UY24399A1 (es) Composicion veterinaria oral conteniendo un agente antibacterial fluorquinolono poseyendo propiedades absorbentes superiores y una duracion extendida de niveles de sangre antimicrobiales terapeuticos, y un metodo para tratar infecciones microbiales e
TH67253A (th) การให้ขนาดยาชนิดแทกเซนแบบเมโทรโนมิค
BR9612813A (pt) Composição antibacteriana de fluoroquinolona veterinária oral para duração prolongada de terapia e método de tratamento
BR0207299A (pt) Composição farmacêutica, solução aquosa e métodos para fabricar e para preparar uma composição, para instruir um humano a ingerir uma composição farmacêutica de liberação imediata e para tratar um humano